Gene Therapy for Glioblastoma Multiforme.

Glioblastoma multiforme (GBM) is a devastating, aggressive primary brain tumor with poor patient outcomes and a five-year survival of less than 10%. Significant limitations to effective GBM treatment include poor drug delivery across the blood-brain barrier, drug resistance, and complex genetic tumor alterations. Gene therapy uses a mechanism different from other GBM therapies to reduce tumor growth and enhance antitumor immunity.

Stable laser-acceleration of high-flux proton beams with plasma collimation.

Laser-plasma acceleration of protons offers a compact, ultra-fast alternative to conventional acceleration techniques, and is being widely pursued for potential applications in medicine, industry and fundamental science. Creating a stable, collimated beam of protons at high repetition rates presents a key challenge. Here, we demonstrate the generation of multi-MeV proton beams from a fast-replenishing ambient-temperature liquid sheet.

Performance of a Point-of-Care Test Kit (Anigen Rapid) to Diagnose Feline Immunodeficiency Virus (FIV) Infection in Domestic Cats Using Saliva Instead of Blood in Australia.

The primary aim of this study was to determine the accuracy of saliva as a proxy for blood in cats using Anigen Rapid FIV point-of-care (PoC) kits and as an easy collection technique applicable for all veterinary clinics and shelters. A secondary aim was to report FIV prevalence in various Australian states/territories and key cat risk factors associated with FIV infection. In total, 382 cats were recruited from patients presenting to private, shelter and teaching hospital veterinary clinics in Australia.

Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.

Objectives: Evaluation of the safety and humoral immunogenicity of ChAdOx1 nCoV-19 as a fourth dose booster in individuals who have had two initial doses of the vaccine and a third dose of BNT162b2.

Methods: COV009 is a safety follow-up study of volunteers enroled in the pivotal pre-licensure ChAdOx1 nCoV-19. In this sub-study, 149 eligible participants were given a fourth dose of ChAdOx1 nCoV-19.

A Method that Maintains Accuracy in the Prediction of Vitamin A Total Body Stores when Population-Based Modeling of a Limited Number of Theoretical Subjects Is Used with Retinol Isotope Dilution.

Background: Retinol isotope dilution (RID) equations are used to predict vitamin A total body stores (TBS). Including population-based ("super-subject") modeling with RID provides group-specific values for the equation coefficients.

Objectives: Objective was to test an approach that would accommodate a limited super-subject sample size without compromising accuracy in RID predictions of TBS.